170
Participants
Start Date
December 16, 2024
Primary Completion Date
February 15, 2028
Study Completion Date
August 15, 2028
ALE.P02
ALE.P02, will be administered by IV infusion according to the assigned arms.
RECRUITING
National Cancer Center, Goyang-si
RECRUITING
National University Cancer Institue, Singapore
RECRUITING
Ospedale San Raffaele, IRCCS, Milan
RECRUITING
IEO - Istituto Europeo di Oncologia, IRCCS, Milan
RECRUITING
NEXT Oncology Virginia, Fairfax
RECRUITING
START Madrid- Centro Integral Oncologico Clara Campal, PAU de Sanchinarro
RECRUITING
Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcón
RECRUITING
Hospital Universitario Virgen De La Victoria, Málaga
RECRUITING
Norton Cancer Institue Downtown, Louisville
RECRUITING
Hospital Universitario Y Politécnico La Fe, Valencia
RECRUITING
Ospedale Santa Maria delle Croci di Ravenna Oncologia, Ravenna
RECRUITING
Changhua Christian Medical Foundation Changhua Christian Hospital, Changhua
RECRUITING
The University of Chicago Medical Center - Oncology, Chicago
RECRUITING
Mayo Foundation for Medical Education and Research - Mayo Cl, Scottsdale
RECRUITING
USC Norris Comprehensive Cancer Center, Los Angeles
RECRUITING
Providence Medical Foundation, Fullerton
RECRUITING
Institut Gustave Roussy, Villejuif
RECRUITING
National Taiwan University Hospital, Taipei
RECRUITING
National Cancer Centre Singapore, Singapore
RECRUITING
Buddihist Tzu Chi Medical Foundation - Taipei Tzu Chi Hospital, Taipei
RECRUITING
Changhua Christian Medical Foundation Changhua Christian Hospital, Changhua
RECRUITING
Yale Comprehensive Cancer Center, New Haven
RECRUITING
Hackensack University Medical Center, Hackensack
RECRUITING
Chinese University of Hong Kong - Prince of Wales Hospital, Shatin
RECRUITING
PU A. Gemelli, Universita Cattolica del Sacro Cuore, Roma
RECRUITING
Centro Ricerche Cliniche Verona, Verona
RECRUITING
START Hospital HM Nou Delfos, Barcelona
RECRUITING
Seoul National University Hospital, Seoul
RECRUITING
Severance Hospital, Yonsei University Health System, Seoul
RECRUITING
Hospital Universitari Vall D Hebron, Barcelona
Lead Sponsor
Alentis Therapeutics AG
INDUSTRY